1. Home
  2. ITOS vs MTRX Comparison

ITOS vs MTRX Comparison

Compare ITOS & MTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • MTRX
  • Stock Information
  • Founded
  • ITOS 2011
  • MTRX 1984
  • Country
  • ITOS United States
  • MTRX United States
  • Employees
  • ITOS N/A
  • MTRX N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • MTRX Engineering & Construction
  • Sector
  • ITOS Health Care
  • MTRX Consumer Discretionary
  • Exchange
  • ITOS Nasdaq
  • MTRX Nasdaq
  • Market Cap
  • ITOS 381.2M
  • MTRX 327.8M
  • IPO Year
  • ITOS 2020
  • MTRX 1990
  • Fundamental
  • Price
  • ITOS $10.18
  • MTRX $14.00
  • Analyst Decision
  • ITOS Hold
  • MTRX Strong Buy
  • Analyst Count
  • ITOS 6
  • MTRX 1
  • Target Price
  • ITOS $10.60
  • MTRX $20.00
  • AVG Volume (30 Days)
  • ITOS 911.6K
  • MTRX 194.3K
  • Earning Date
  • ITOS 08-07-2025
  • MTRX 05-07-2025
  • Dividend Yield
  • ITOS N/A
  • MTRX N/A
  • EPS Growth
  • ITOS N/A
  • MTRX N/A
  • EPS
  • ITOS N/A
  • MTRX N/A
  • Revenue
  • ITOS $35,000,000.00
  • MTRX $742,408,000.00
  • Revenue This Year
  • ITOS N/A
  • MTRX $9.98
  • Revenue Next Year
  • ITOS N/A
  • MTRX $20.42
  • P/E Ratio
  • ITOS N/A
  • MTRX N/A
  • Revenue Growth
  • ITOS 177.89
  • MTRX N/A
  • 52 Week Low
  • ITOS $4.80
  • MTRX $8.61
  • 52 Week High
  • ITOS $18.13
  • MTRX $15.75
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 67.57
  • MTRX 66.73
  • Support Level
  • ITOS $9.95
  • MTRX $13.31
  • Resistance Level
  • ITOS $10.20
  • MTRX $14.07
  • Average True Range (ATR)
  • ITOS 0.15
  • MTRX 0.41
  • MACD
  • ITOS -0.09
  • MTRX 0.10
  • Stochastic Oscillator
  • ITOS 90.00
  • MTRX 89.40

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About MTRX Matrix Service Company

Matrix Service Co is an engineering and construction provider for large industrial projects, primarily in the oil and gas, power, petrochemical, industrial, mining, and minerals markets. It offers engineering, fabrication, construction, and maintenance services, operating across three segments namely Utility and Power Infrastructure; Process and Industrial Facilities; and Storage and Terminal Solutions.

Share on Social Networks: